foxo4-dri peptide human clinical trial Buy FOXO4-DRI 10mg | Third-Party
Description
Injection Choose the injection site: Subcutaneous injections are typically injected into the abdomen or optionally the upper/outer thigh area
103 JinJ
2009;34(Suppl 1):S18695
After VB12 therapy, serum VB12 levels increased significantly in all patients, and there was a statistically significant difference between the treatment groups (p 0.05), and after the therapy, the levels were detected as 602.0 156.1, 483.4 144.8, and 565.5 108.1 pg/mL, respectively (p 0.05)
